Zdrowie i gospodarka · 21/06/2005
FDA to Host Public Workshop on Leukocyte Reduction in Blood and Blood Components
The US Food and Drug Administration (FDA) will host a public workshop to discuss updates on leukocyte reduction in blood and blood components, a process used to remove white blood cells from donated blood products.
Source: Federal Register — Food and Drug AdministrationOpen original release →